![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 1660-2862|6|4|139-147
ISSN: 1660-2854
Source: Neurodegenerative Diseases, Vol.6, Iss.4, 2009-06, pp. : 139-147
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Increased Cerebrospinal Fluid Aβ38/Aβ42 Ratio in Alzheimer Disease
Neurodegenerative Diseases, Vol. 2, Iss. 5, 2006-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease Families with
Neurodegenerative Diseases, Vol. 8, Iss. 4, 2011-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: The Present and the Future
Neurodegenerative Diseases, Vol. 8, Iss. 6, 2011-06 ,pp. :